CLOSE X

JB CHEMICALS & PHARMACEUTICALS LTD.

NSE : JBCHEPHARMBSE : 506943ISIN CODE : INE572A01036Industry : Pharmaceuticals & DrugsHouse : Private
BSE1654.553.1 (+0.19 %)
PREV CLOSE ( ) 1651.45
OPEN PRICE ( ) 1638.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 32230
TODAY'S LOW / HIGH ( )1638.00 1665.00
52 WK LOW / HIGH ( )1303 2029
NSE1655.105 (+0.3 %)
PREV CLOSE( ) 1650.10
OPEN PRICE ( ) 1642.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1655.10 (13)
VOLUME 499262
TODAY'S LOW / HIGH( ) 1640.50 1665.00
52 WK LOW / HIGH ( )1385.75 2030
Select year
Particulars
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Operational & Financial Ratios
 
 
 
 
 
   Earnings Per Share (Rs)
42.37  
35.61  
52.97  
49.86  
57.96  
   CEPS(Rs)
53.36  
44.52  
33.89  
29.68  
33.46  
   DPS(Rs)
15.50  
12.25  
17.75  
16.50  
16.50  
   Book NAV/Share(Rs)
209.75  
179.35  
304.83  
268.04  
234.17  
   Tax Rate(%)
25.67  
26.46  
26.16  
23.54  
24.86  
Margin Ratios
 
 
 
 
 
   Core EBITDA Margin(%)
25.40  
24.76  
21.28  
21.81  
27.23  
   EBIT Margin(%)
22.15  
22.08  
18.09  
20.50  
29.58  
   Pre Tax Margin(%)
21.86  
20.85  
16.98  
20.29  
29.22  
   PAT Margin (%)
16.25  
15.33  
12.54  
15.51  
21.96  
   Cash Profit Margin (%)
20.46  
19.17  
16.04  
18.44  
25.32  
Performance Ratios
 
 
 
 
 
   ROA(%)
13.58  
12.60  
11.44  
13.69  
19.55  
   ROE(%)
21.81  
21.49  
18.51  
19.89  
27.64  
   ROCE(%)
26.73  
25.23  
22.79  
25.48  
36.53  
   Asset Turnover(x)
0.84  
0.82  
0.91  
0.88  
0.89  
   Sales/Fixed Asset(x)
1.40  
1.32  
1.46  
1.63  
1.73  
   Working Capital/Sales(x)
3.15  
3.66  
3.36  
2.86  
1.69  
Efficiency Ratios
 
 
 
 
 
   Fixed Capital/Sales(x)
0.71  
0.76  
0.69  
0.61  
0.58  
   Receivable days
67.54  
63.93  
63.16  
69.29  
65.62  
   Inventory Days
46.37  
47.24  
46.91  
55.55  
55.59  
   Payable days
106.33  
91.86  
72.35  
89.07  
92.33  
Valuation Parameters
 
 
 
 
 
   PER(x)
38.29  
46.32  
18.61  
31.59  
21.63  
   PCE(x)
30.40  
37.05  
29.08  
26.54  
18.73  
   Price/Book(x)
7.73  
9.20  
6.47  
5.88  
5.35  
   Yield(%)
0.96  
0.74  
0.90  
1.05  
1.32  
   EV/Net Sales(x)
6.42  
7.42  
4.99  
5.01  
4.74  
   EV/Core EBITDA(x)
23.49  
27.68  
22.28  
20.84  
14.40  
   EV/EBIT(x)
27.96  
32.49  
26.59  
23.81  
16.04  
   EV/CE(x)
7.29  
7.88  
5.19  
3.96  
3.77  
   M Cap / Sales
6.45  
7.35  
4.84  
5.02  
4.74  
Growth Ratio
 
 
 
 
 
   Net Sales Growth(%)
12.45  
10.63  
29.91  
18.69  
15.09  
   Core EBITDA Growth(%)
14.56  
32.37  
21.11  
-13.39  
57.02  
   EBIT Growth(%)
12.98  
34.59  
15.93  
-15.58  
71.55  
   PAT Growth(%)
19.35  
34.79  
6.21  
-13.93  
64.66  
   EPS Growth(%)
18.98  
-32.77  
6.22  
-13.98  
64.66  
Financial Stability Ratios
 
 
 
 
 
   Total Debt/Equity(x)
0.00  
0.13  
0.23  
0.01  
0.02  
   Current Ratio(x)
2.12  
1.76  
2.56  
2.91  
2.76  
   Quick Ratio(x)
1.66  
1.37  
1.87  
2.01  
2.25  
   Interest Cover(x)
76.66  
17.95  
16.40  
99.60  
83.43  
   Total Debt/Mcap(x)
0.00  
0.01  
0.04  
0.00  
0.00  
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors